Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (1-10 of 785) with videos related to

Pageof 79
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Endothelin Antagonism and Insulin's Vascular EffectsSubodh Verma
The American Journal of Cardiology|November 20, 2019
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular BenefitsSubodh Verma
Cardiovascular Research|December 19, 2019
The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fractionSubodh Verma
The Canadian Journal of Cardiology|August 17, 2004
C-reactive protein incites atherosclerosisSubodh Verma
JACC. Basic to Translational Science|March 7, 2020
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?Subodh Verma
Current Opinion in Cardiology|September 30, 2025
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal ruptureMarc Ruel, Subodh Verma
Canadian Journal of Diabetes|December 29, 2019
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes MellitusAbhinav Sharma, Subodh Verma
Clinical Chemistry|March 27, 2013
Evolving role of microparticles in the pathophysiology of endothelial dysfunctionFina Lovren, Subodh Verma
Current Opinion in Cardiology|January 16, 2018
What's hot in heart valve disease 2018?Bobby Yanagawa, Subodh Verma
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2019
Transcatheter aortic valve implantation for severe aortic stenosisAnkit Garg, Subodh Verma
Pageof 79

Showing results (1-10 of 785) with videos related to

Sort By:
Pageof 79
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Endothelin Antagonism and Insulin's Vascular EffectsSubodh Verma
The American Journal of Cardiology|November 20, 2019
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular BenefitsSubodh Verma
Cardiovascular Research|December 19, 2019
The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fractionSubodh Verma
The Canadian Journal of Cardiology|August 17, 2004
C-reactive protein incites atherosclerosisSubodh Verma
JACC. Basic to Translational Science|March 7, 2020
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?Subodh Verma
Current Opinion in Cardiology|September 30, 2025
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal ruptureMarc Ruel, Subodh Verma
Canadian Journal of Diabetes|December 29, 2019
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes MellitusAbhinav Sharma, Subodh Verma
Clinical Chemistry|March 27, 2013
Evolving role of microparticles in the pathophysiology of endothelial dysfunctionFina Lovren, Subodh Verma
Current Opinion in Cardiology|January 16, 2018
What's hot in heart valve disease 2018?Bobby Yanagawa, Subodh Verma
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2019
Transcatheter aortic valve implantation for severe aortic stenosisAnkit Garg, Subodh Verma
Pageof 79